Newlect Tablets 0.5 mg (Rasagiline Mesylate)
Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
MFDS item code 201907616 · Approved 2019.10.31
This product's status changed to Expired on 2024.10.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of idiopathic Parkinson's disease
This medication is used for the treatment of patients with idiopathic Parkinson's disease. It can be used initially as monotherapy or as an adjunctive therapy to dopamine agonists. Additionally, it is effective as an adjunct therapy to levodopa in patients who experience motor fluctuations, particularly during the end of dose fluctuations when the effect of the medication diminishes. This helps to improve Parkinson's disease symptoms and enhances the quality of daily life for patients.
This medicine is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy with a dopamine agonist: Administer 1mg orally once daily. 2) Adjunctive therapy with levodopa: The recommended initial dose for patients taking levodopa is 0.5mg once daily. If well tolerated and the clinical response is insufficient, the dose may be increased to 1mg once daily. This medicine may be taken with or without food.
This medicine should not be used in patients who are allergic to its active ingredient or any other ingredients. It should also not be administered to patients who are currently taking monoamine oxidase inhibitors (MAO inhibitors) or who have stopped taking them within the last 2 weeks. Particularly, patients taking medications such as pethidine, tramadol, or dextromethorphan should not use this medicine together, and it should be avoided in patients with moderate to severe liver impairment. This medication can cause various adverse reactions, with common symptoms including headache, depression, hallucinations, dizziness, dermatitis, nausea, constipation, and musculoskeletal pain. Rarely, serious side effects such as myocardial infarction, cerebrovascular accidents, malignant hyperthermia, and acute renal failure have been reported, so any unusual symptoms should be discussed with a physician immediately. When used with other dopaminergic treatments, there may be occurrences of hypotension or movement disorders, so caution is advised. Drowsiness or sudden sleep episodes may occur during treatment, so caution should be taken while engaging in activities such as driving or operating machinery. Especially, combining this medication with other MAO inhibitors, antidepressants, or sympathomimetics can lead to serious side effects, so it should be discussed with a physician. During pregnancy or lactation, careful consideration should be given to the use of this medication, and its safety in pediatric patients has not been established. In case of overdose, symptoms such as mild euphoria, hypertensive crisis, and serotonin syndrome may appear, and immediate medical attention should be sought.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is important to store it at a cool temperature between 1 degree and 25 degrees Celsius to maintain its effectiveness.
White, round tablets
30 tablets (10 tablets/PTP × 3), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Hana Lundbeck Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Korea Lundbeck Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.